Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 14, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Sooma raised $5.5 million for its depression-treating neuromodulation technology. Fast Five hosts Sean Whooley and Danielle Kirsh talk about what the company's technology does and what it plans are for the funds. 
SetPoint Medical won FDA breakthrough designation for its nerve stimulation technology for multiple sclerosis. Hear more about the technology and the executives' optimism about the future of the technology. 
Abbott is launching its latest Navitor TAVI system in the U.S. Whooley talks about the technology and Abbott's TAVR market history. 
GE Healthcare has established a foundation to advance access to healthcare. The Fast Five hosts talk about what the new foundation will focus on and what the future holds. 
A former Stimwave CEO was recently convicted of healthcare fraud. Learn more about what the CEO was found guilty of and how the case unfolded.